J Korean Pain Soc.  1994 Nov;7(2):199-204.

Comparison of Anesthesiologist controlled Sedation and Patient Controlled Sedation during Neurolytic Pain Block and Regional Anesthesia

Affiliations
  • 1Department of Anesthesiology, Dong-A University College of Medicine, Pusan, Korea.

Abstract

The purpose of this study is to evaluate the feasibility, advantages/disadvantages of patientcontrolled sedation (PCS) compared to anesthesiologist-controlled sedation (ACS) during neurolytic pain block and regional anesthesia. Forty patients were divided randomly into two groups of 20 patients each. Group l (ACS) received 0.01 mg kg(-1) intravenous midazolam and 0.5 microgram kg(-1) fentanyl intravenously by anesthesiologist just before, 30, and 60 minutes after the procedure to acheive sedation, Group 2 (PCS) patients self-administered a mixture of midazolam (0.4 mg) and fentanyl (20 microgram) using a syringe type infusion pump (Terumo, Japan) to acheive sedation. Considering the dermographics of patients, the types and durations of procedure performed, the level of average sedation the comfort level were similar in both groups. But the doses of midazolam and fentanyl administerd in group 2 were smaller than those in group 1 (p <0.01). Patients in PCS group showed their level of sedation more proper than did those in ACS group. However, patients in ACS group rated their level of comfort higher than did those in PCS group. The findings of this study indicate that PCS using a combination of midazolam and fentanyl is a fafe and effective technique. More studies are, however, needed to determinc the best choice of drug (s), doses, lock-out intervals, and possible use of continuous infusion with patient-controlled sedation.

Keyword

Patient-controlled sedation; Neurolytic block; Regional anesthesia

MeSH Terms

Anesthesia, Conduction*
Fentanyl
Humans
Infusion Pumps
Midazolam
Syringes
Fentanyl
Midazolam
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr